Skip to main content
Fig. 2 | BMC Cardiovascular Disorders

Fig. 2

From: Clinical benefits and risks of anticoagulation therapy according to the degree of chronic kidney disease in patients with atrial fibrillation

Fig. 2

Kaplan–Meier plots of the rate of net adverse clinical events (NACE) according to creatinine clearance in all cohorts. (A) Rate of NACE according to the stage of chronic kidney disease. (B) Rate of NACE in patients treated with (bold line) or without (dotted line) anticoagulation therapy according to the stage of chronic kidney disease

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us